NB02 (Poseltinib) combined rituximab and lenalidomide in R/ R PCNSL (POTENTIAL-P): Initial results of safety lead-in cohort.

Citations

WEB OF SCIENCE

0
제목
NB02 (Poseltinib) combined rituximab and lenalidomide in R/ R PCNSL (POTENTIAL-P): Initial results of safety lead-in cohort.
저자
Yang, Deok-Hwan; Oh, Sung Yong; Jeon, Youngwoo; Song, Ga-Young; Kim, Seokjin; Yoon, Sang Eun; Kim, Tong-Yoon; Lee, Ji Hyun; Kim, Hye Ryeon; Koh, Youngil; Song, Han; Lee, Myungsea; Kim, Won Seog
DOI
10.1182/blood-2025-5463
발행일
2025-11-03
유형
Meeting Abstract
저널명
Blood
권
146
페이지
5463 ~ 5464